| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |